CJC-1295 (No DAC)

Short GHRH analogue used to amplify a GH pulse with a GHRP. Not the weekly DAC form.

What it does / how it works

A short GHRH analogue. It tells the pituitary to release GH in a pulse. Without DAC it dies quickly, so it is paired with a GHRP at the same time to amplify one physiological pulse.

Class Short-acting GHRH analogue
Typical vial 5 or 10 mg
Reconstitution 2 mL BAC per 5 mg
Storage after mix 2–8°C, use within 28 days

Protocol

Goal Dose How often How long Route
Weeks 1-12 with Ipa CJC 100-200 mcg + Ipa 100-200 mcg Nightly or 2x daily, empty stomach 8-12 weeks SubQ
Solo option 200-300 mcg Nightly 8-12 weeks SubQ
Off None Stop 4 weeks off –

Watch: Do not confuse with CJC-1295 with DAC.

CJC-1295 (No DAC) FAQ — Australia

ELV8 Labs offers CJC-1295 (No DAC) in 10 mg vials, third-party tested at a leading Australian university. Also available as a blend with Ipamorelin. For research purposes only.
They are the same compound. CJC-1295 without DAC, Modified GRF (1-29), and Mod GRF are all names for the same 29-amino-acid GHRH analogue. Australian suppliers may use any of these names interchangeably.
The No DAC version produces pulsatile GH release that more closely mimics natural physiology, while the DAC version provides sustained elevation. Most Australian research protocols reference the No DAC version, particularly when combined with Ipamorelin. See the DAC version protocol for comparison.
Published research identifies approximately 100 mcg as the saturation dose — the point of maximum GH release per pulse. Higher single doses do not proportionally increase GH output, which is why multiple daily administrations at 100 mcg are preferred over single larger doses.
Published research identifies approximately 100 mcg as the saturation dose — the point of maximum GH release per pulse. Higher single doses do not proportionally increase GH output, which is why multiple daily administrations at 100 mcg are preferred over single larger doses.

Recommended Supplier — CJC-1295 (No DAC) Australia

Our products offer premium-grade research materials with independent testing at a leading Australian university. Every batch is strictly verified by RP-HPLC and LC-MS. For research purposes only.

Related Research — Australia

Explore similar research-grade peptides, selected to complement your research needs.

Tesamorelin + Ipamorelin

Tesamorelin target is 1-2 mg daily. Ipamorelin target....

Super Human Blend

One serving: L-Arginine 110 mg, L-Ornithine 110 mg,....

Semax + Selank

Short course. Intranasal preferred. Then 2-4 weeks off.....

Retatrutide + Cagrilintide

5+5 mg is a late stock, not a....
Select your currency
AUD Australian dollar